Spin off . That could be 70-80 million dollars company Approximate value Auberna 20-25 million Ma genetics 10-15 million Australian license +mcl agreement 25-30 million
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%